These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Creatine phosphokinase: interpretation of the test results]. Sugita H; Furukawa T; Chiba K Nihon Rinsho; 1969 Mar; ():Suppl:1072-7. PubMed ID: 4948291 [No Abstract] [Full Text] [Related]
4. [Serum pyruvate kinase (PK) in the diagnosis of neuromuscular diseases]. Chen Y Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Dec; 18(6):338-41. PubMed ID: 3836824 [No Abstract] [Full Text] [Related]
5. Failure of the prednisolone test in neuromuscular disorders. Vita G; Natoli M; Dattola R; Messina C Ital J Neurol Sci; 1982 Jul; 3(2):127-8. PubMed ID: 7118524 [No Abstract] [Full Text] [Related]
6. [Diagnosis and its problems in neuromuscular diseases, with special reference to biochemical examinations--enzymatic diagnosis]. Furukawa T Nihon Rinsho; 1969 Jan; 27(1):96-102. PubMed ID: 4890036 [No Abstract] [Full Text] [Related]
7. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy. Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925 [No Abstract] [Full Text] [Related]
8. Genetic counselling in neuromuscular diseases in Western Australia. Hurse PV; Kakulas BA Proc Aust Assoc Neurol; 1974; 11():145-53. PubMed ID: 4469625 [No Abstract] [Full Text] [Related]
9. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects]. Koufen H; Consbruch U Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032 [No Abstract] [Full Text] [Related]
10. [Creatine phosphokinase in differential diagnosis of muscular dystrophies]. Guglielmetti P G Clin Med; 1965 Feb; 46(2):155-64. PubMed ID: 5862841 [No Abstract] [Full Text] [Related]
11. [The value of additional diagnosis in the differentiation between neuropathies and myopathies]. Delcker A; Schlote W Nervenarzt; 1990 Apr; 61(4):239-43. PubMed ID: 2162009 [No Abstract] [Full Text] [Related]
12. [New CPK mass screening test in the early diagnosis of muscular diseases]. Beckmann R; Scheuerbrandt G; Antonik A; Antonik S Fortschr Med; 1974 Nov; 92(33):1348-54. PubMed ID: 4457445 [No Abstract] [Full Text] [Related]
13. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures. Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781 [No Abstract] [Full Text] [Related]
14. [Neonatal screening for duchenne myopathy by serum elevation of creatine phosphokinase activity. 5 years experience]. Plauchu H; Dellamonica C; Pascal B; Jolivet MJ; Guibaud P; Cotte J; Robert JM J Genet Hum; 1981 Mar; 29(1):59-69. PubMed ID: 7334342 [TBL] [Abstract][Full Text] [Related]
15. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy. Perry TB; Fraser FC Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611 [No Abstract] [Full Text] [Related]
20. Steroid-CPK test. A new diagnostic aid for muscular dystrophy and its carriers? Sen S; Das PK Eur Neurol; 1978; 17(5):258-64. PubMed ID: 710453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]